Haleon plc, a leading global consumer healthcare company, is headquartered in Great Britain and operates extensively across Europe, North America, and Asia. Founded in 2022, Haleon emerged from a spin-off of GlaxoSmithKline's consumer healthcare division, marking a significant milestone in the industry. Specialising in over-the-counter medicines, oral health, and wellness products, Haleon offers a diverse portfolio that includes well-known brands such as Sensodyne, Panadol, and Voltaren. These products are distinguished by their commitment to science-backed efficacy and consumer trust. With a strong market position, Haleon is dedicated to improving everyday health and well-being, making it a notable player in the consumer healthcare sector. The company's focus on innovation and sustainability further enhances its reputation as a forward-thinking leader in the industry.
How does Haleon plc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Haleon plc's score of 85 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Haleon plc reported carbon emissions of approximately 2,000,000 kg CO2e for Scope 1 and about 3,000,000 kg CO2e for Scope 2, totalling around 5,000,000 kg CO2e for both scopes combined in Great Britain. This reflects a commitment to reducing net Scope 1 and 2 emissions by 100% by 2030, using a 2020 baseline. Additionally, Haleon aims to achieve net zero carbon emissions across all scopes by 2040, in alignment with the Climate Pledge and Race to Zero initiatives. Globally, Haleon’s emissions for 2024 included approximately 68,000,000 kg CO2e for Scope 1 and about 121,000,000 kg CO2e for Scope 2, with a significant Scope 3 total of approximately 2,529,000,000 kg CO2e. The company has set ambitious targets to reduce Scope 3 emissions by 42% by 2030, compared to a 2022 baseline. Haleon’s near-term targets, as certified by the Science Based Targets initiative (SBTi), include a 95% reduction in absolute Scope 1 and 2 emissions by 2030. The company is actively working towards these goals, with interim targets to reduce emissions from both scopes by 50% by 2030. Overall, Haleon plc is committed to significant reductions in carbon emissions, demonstrating leadership in sustainability within the consumer durables sector.
Access structured emissions data, company-specific emission factors, and source documents
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Scope 1 | 59,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 2 | 37,000,000 | 00,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Scope 3 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Haleon plc is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.